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The nature of the invasive growth pattern and microvessel density (MVD) have been suggested to be predictors of prognosis in
primary colorectal cancer (CRC) and colorectal liver metastases. The purpose of the present study was to determine whether these
two histological features were interrelated and to assess their relative influence on disease recurrence and survival following surgical
resection. Archival tissue was retrieved from 55 patients who had undergone surgical resection for primary CRC and matching
liver metastases. The nature of the invasive margin was determined by haematoxylin and eosin (H&E) histochemistry. Microvessel
density was visualised using immunohistochemical detection of CD31 antigen and quantified using image capture computer software.
Clinical details and outcome data were retrieved by case note review and collated with invasive margin and MVD data in a statistical
database. Primary CRCs with a pushing margin tended to form capsulated liver metastases (Po0.001) and had a significantly better
disease-free survival than the infiltrative margin tumours (log rank P¼0.01). Primary cancers with a high MVD tended to form high
MVD liver metastases (P¼0.007). Microvessel density was a significant predictor of disease recurrence in primary CRCs (P¼0.006),
but not liver metastases. These results suggest that primary CRCs and their liver metastases show common histological features. This
may reflect common mechanisms underlying the tumour–host interaction.
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Approximately 50% of patients with colorectal cancer (CRC)
will be cured by surgical resection. The remainder will develop
disease recurrence, with the liver being the commonest site for
metastatic spread (Poston, 2004). In selected patients, liver
metastases may be amenable to surgical resection with 5-year
survival rates of 35–40% (Lodge et al, 2005). For those with
unresectable liver metastases, or who recur after liver resection, the
prognosis is poor.
Several histological variables have been identified as predictors
of disease recurrence, including the degree of tumour differentia-
tion, the depth of local invasion, the presence of nodal metastases,
and evidence of extramural vascular or perineural invasion. In
1987, Jass et al (1987) identified the nature of the invasive growth
pattern as a prognostic indicator in CRC, with infiltrative cancers
having a worse prognosis compared to pushing cancers. The
invasive growth pattern of colorectal liver metastases was
subsequently shown to predict outcome following liver resection,
with capsulated and noncapsulated metastases being associated
with 5-year survival rates of 76 and 31%, respectively (Okano et al,
2000). However, it is not known whether the invasive growth
patterns of the primary cancers and their liver metastases are
related, or whether the growth pattern is a genetically determined
feature of the tumour, a response to local tumour–stromal
interaction, or a combination of the two.
Angiogenesis is a fundamental requirement for tumour growth,
invasion, and metastasis formation (Folkman, 1986). The assess-
ment of microvessel density (MVD) is frequently used to quantify
angiogenesis in archival tissue (Hlatky et al, 2002), although its use
as a prognostic indictor is controversial. In breast cancer (Uzzan
et al, 2004), non-small cell lung carcinoma (Ushijima et al, 2001)
and melanoma (Ribatti et al, 2003), a high MVD is associated with
poor outcome. In CRC, a high MVD has been shown to predict
disease recurrence and survival in some studies (Saclarides et al,
1994;Tanigawa et al, 1997), whereas other studies have shown an
association between high MVD and improved survival (Prall et al,
2003) or have concluded that MVD failed to provide additional
prognostic information (Cianchi et al, 2002).
The nature of the invasive growth pattern and the angiogenic
response both influence a tumour’s metastatic capability. However,
it is not known if these processes are interrelated. It is possible
that different invasive phenotypes are associated with different
angiogenic responses, which in turn influence their metastatic
capability. The current study aimed to investigate the relationship
between the invasive growth patterns observed in primary CRC
and liver metastases, the association with MVD, and the impact on
clinical outcome.
MATERIALS AND METHODS
Patients who had undergone potentially curative resection for CRC
and colorectal liver metastases were identified from histopathology
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sdatabases at St James’s University Hospital, Leeds and the Royal
Liverpool University Hospital, Liverpool, between June 1994 and
June 2000. Patients with conditions known to predispose to CRC
(e.g. inflammatory bowel disease, familial adenomatous polyposis),
and those who had undergone preoperative chemo-radiotherapy
were excluded. Patients who died as a complication of their
surgery were excluded as their death was unrelated to tumour
biology and introduced a confounding influence on survival
analysis. Patients included had primary CRC resected and were
either diagnosed with synchronous liver metastases and underwent
resection or developed metachronous liver disease on follow-up
surveillance and underwent resection. A large proportion of
patients in the study had synchronous metastases. Demographics
are shown in Table 1 for the total 55 patients included.
Local ethics committee approval was obtained for the study
(Leeds West Research Ethics Committee, RL04/6669). Patient
demographics were entered into a statistical database (SPSSv12.0,
Chicago, IL, USA) and collated with clinical and histological data.
Histochemical analysis of the invasive margin
Archival paraffin-embedded tissue samples of matched primary
CRC and liver metastases were retrieved for all patients. Thin
sections of 4mm were prepared, dewaxed in xylene, rehydrated in
graded ethanol solutions, and stained with haematoxylin and eosin
(H&E) using a standard protocol.
The nature of the invasive margin was determined by two-
independent observers and checked by a consultant histopatho-
logist (NS). The invasive margin of the primary cancers were
classified as either pushing or infiltrative based on the predomi-
nant morphology, as defined by Jass et al (1987). A modified
classification based on Yasui ( Lunevicius et al, 2001) was used for
liver metastases, with metastases being classified as capsulated if
450% of the margin exhibited a fibrous capsule separating
tumour from stroma.
MVD analysis
Sections of 4mm sections were dewaxed in Histoclear (National
Diagnostics, UK), rehydrated through graded ethanol, and washed
with tap water for 10min. Endogenous peroxidase activity was
blocked with 0.6% (vv
 1)H 2O2 in 100% methanol for 10min at
room temperature. Antigen was retrieved by pressure cooking
for 2min in citrate buffer solution (pH 6.0). Sections were blocked
with 5% (vv
 1) goat serum (Sigma Aldrich, Dorset, UK) in
phosphate-buffered saline (PBS) for 30min at room temperature,
and then incubated with anti-CD31 antibody (Dakocytomation,
Ely, Cambridgeshire, UK) at 1:20 dilution in PBS overnight at
41C. Sections were washed twice with PBS and then incubated
with alkaline phosphatase–conjugated goat anti-mouse IgG (1:200
dilution; Dakocytomation, Ely, UK) for 60min at room tempera-
ture. Following two further washes in PBS, the substrate was
developed using the Vector Red ALP kit (Vector Laboratories,
Peterborough, UK). Sections were counterstained with methyl
green (Vector Laboratories, Peterborough, UK) for 10min, washed
in acetone, and dehydrated in a series of graded ethanol and
Histoclear. Slides were mounted in diphenylxylene (BDH, Poole,
UK) and cover slipped. Negative controls were performed in
parallel, with omission of the primary antibody incubation step.
Anti-CD31 treated sections were examined with a Nikon Eclipse,
(Kingston-upon-Thames, UK), E1000 microscope. Each section
was divided at low power ( 40 optical magnification) into three
areas representing the stromal interface, tumour margin, and the
tumour centre. Five random high-power fields ( 100 optical
magnification) were captured from each of the three tumour areas
using a Basler A113
t Matrix-camera (Basler Vision Technology,
UK) connected to a computer running Lucia G
t software (Version
4.6 Nikon). A template was created by setting a colour threshold,
which clearly identified the CD31-positive endothelial cells and a
fixed light intensity was used throughout the analysis. MVD counts
were recorded from each of the five high-power fields and
averaged to give the mean MVD at the stromal interface, the
tumour margin, and the tumour centre. The MVD was calculated
as the number of vessels per mm
2. Twenty tissue samples were
reanalysed 2 months following the initial analysis to assess intra
and inter observer variation.
Statistical analysis
Statistical analysis was performed using SPSS for windows (SPSS
v12.0, CA, USA). The relationship between the invasive growth
patterns of the primary CRCs and their liver metastases was
tested using the w
2 test. The association between MVD and invasive
growth pattern was analysed using the Mann–Whitney U-test.
Spearman’s correlation was performed to investigate the relation-
ship of MVD in the primary cancer with that in the liver metastases
and inter/intra observer variation. The difference in mean MVD
between cancers that formed liver metastases and those that did
not was tested using the Mann–Whitney U-test. The influence of
mean MVD on disease-free and overall survival was analysed using
Kaplan–Meier survival curves and log rank test. For all analyses a
P value of o0.05 was deemed to be significant.
RESULTS
Routine histological analyses of the resected primary CRCs are
shown in Table 1. Twenty-nine (53%) patients were found to have
Table 1 Histological and clinical demographics of patients with CRC
included in the study
Clinicopathological details of patients (n¼89) Frequency
Patient age mean 63
Range (41–80)
Patient sex
Male 26
Female 29
Dukes stage at first presentation
A1
B1 8
C3 6
T stage
11
23
34 4
47
N stage
02 7
11 9
29
M stage
02 6
12 9
Tumour site
Right-sided tumour 19
Left-sided tumour 13
Rectal tumour 23
CRC¼colorectal cancer. Variables relate to the time of surgical resection for primary
CRC.
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ssynchronous liver metastases, whereas 26 (47%) patients deve-
loped metachronous liver disease. None of the patients had
synchronous primary CRCs.
The mean length of follow-up for all patients was 47 months
(range 6–171 months). A total of 28/55 (51%) patients were
alive on completion of the study. The mean overall survival
following resection of the primary cancers was 47 months (range:
6–171 months) and 36.3 months (range: 0–118 months) following
liver resection. The mean disease-free survival following resection
of primary cancers was 30 months (3–88 months) and 28 months
(4–118 months) following liver resection. A total of 17/55 (30.9%)
patients developed disease recurrence following liver resection:
recurrence at the primary site (2), liver recurrence (7), lung
recurrence (5), and multisite recurrence (3).
The scoring system for MVD was shown to be reliable and
reproducible with significant correlations between the inter-
observer (r¼0.75, Po0.001) and intra-observer (r¼0.71,
Po0.01) variation when 20 sections were re-scored.
Relationship between the invasive growth patterns in
matched primary CRCs and liver metastases
Twenty-six (47%) of the primary cancers had a pushing and 29
(53%) an infiltrative growth pattern (Figure 1A and B). A total of
18/26 (69.2%) primary cancers with a pushing growth pattern
formed liver metastases with a capsulated phenotype (Figure 1C)
compared to only 5/29 (17.2%) primary cancers with an infiltrative
growth pattern (w
2, Po0.001). Similarly, primary cancers with an
infiltrative growth pattern were significantly more likely to form
noncapsulated metastases (Figure 1D) (Po0.001).
Colorectal cancers with a pushing margin had a significantly
better disease-free survival than the infiltrative margin tumours
(log rank P¼0.017). Significant differences were not observed
in overall survival (log rank P¼0.10). Similarly capsulated and
noncapsulated liver metastases in terms of disease-free survival
(log rank P¼0.32) or overall survival (log rank P¼0.26).
Relationship between MVD in matched primary
CRC and liver metastases
The mean MVD was determined at the stromal interface, the
tumour margin, and the tumour centre for each CRC and liver
metastasis (Figure 2). Primary cancers with a high MVD at the
tumour margin tended to form liver metastases with a high MVD
margin, whereas primary cancers with a low margin MVD tended
to form metastases with a low MVD margin (P¼0.001) (Figure 3).
A similar positive correlation was observed when the primary and
liver tumour centres were compared (P¼0.011), but not on
comparison of the stromal margins (P¼0.149).
The cohort was divided into high and low groups using the
mean MVD values. The primary CRCs had a mean MVD of
65.2vesselsmm
 2 (95% CI: 52.3–79.5), whereas the liver metas-
tases had a mean MVD of 84.9vesselsmm
 2 (95% CI: 66.8–103.1)
at the tumour margin. The disease-free survival for the high
and low MVD groups were not found to be significant following
resection of primary CRC (log rank P¼0.13) (Figure 4A), but
significant following resection of colorectal liver metastases (log
rank P¼0.036) (Figure 4B).
Relationship between invasive growth pattern and MVD
in primary CRCs and liver metastases
When mean MVD measurements taken from the stromal interface,
the tumour margin, and the tumour centre were compared
A
C
B
D
Figure 1 (A) Photomicrograph of a typical ‘pushing margin’ primary CRC. Original magnification was  20. The H&E shows the penetration of normal
tissues as a single advancing front. (B) Photomicrograph of a typical ‘infiltrative margin’ primary CRC. Original magnification was  20. The H&E shows the
diffuse manner of invasion in this margin, with widespread penetration of normal tissues. (C) Photomicrograph of a typical ‘capsulated’ colorectal liver
metastases. Original magnification was  20. The H&E shows a fibrous capsule separating the tumour from stroma. (D) Photomicrograph of a typical
‘noncapsulated’ colorectal liver metastases. Original magnification was  20. The H&E shows the adjacent tumour and stroma with no fibrous capsule.
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sbetween pushing and infiltrative primary cancers, a significant
difference was only observed in the margin MVD (Table 2).
Pushing cancers were associated with a higher margin MVD
(mean: 82.4vesselsmm
 2, 95% CI: 58.6–106.2) compared to
infiltrative cancers (mean: 51.3 vesselsmm
 2, 95% CI: 38.9–63.7,
P¼0.034). A similar, but nonsignificant, trend to higher MVD was
observed in the centre of pushing compared to infiltrative cancers
(P¼0.077, Table 2). Differences in MVD between capsulated and
noncapsulated liver metastases were not significant at the stromal
interface, tumour margin, or tumour centre.
DISCUSSION
The prognosis and choice of therapy for patients with CRC is based
on histological analysis and tumour stage. Jass et al (1987)
identified the invasive margin in primary CRCs as a prognostic
indicator, and similarly Okano et al (2000) showed that the growth
pattern of colorectal liver metastases also predicted outcome.
We have shown that pushing CRCs tend to develop capsulated
liver metastases, whereas infiltrative cancers tended to develop
noncapsulated liver metastases. Better disease-free survival was
seen in primary cancers with a pushing margin, and this concurs
with the previously reported finding of Jass et al (1987) and
Cianchi et al (1997). However, unlike Okano no survival benefit
was demonstrated between patients with capsulated and non-
capsulated liver metastases. To date, no other group has compared
the primary cancer phenotype with the invasive growth pattern of
subsequent liver metastases.
Only the tumour margin MVD was found to be significant
during the analysis of colorectal primary and liver metastases.
Therefore, only the margin MVD will be used in further discussion.
Tumour vascularity has been shown to be a strong prognostic
factor and to correlate with aggressiveness and metastatic potential
in many cancers. High MVD has been associated with a poorer
outcome in some studies of CRC (Saclarides et al, 1994; Tanigawa
et al, 1997). Our results concur with this, with high MVD primary
cancers and liver metastases having a reduced disease-free
survival. A trend to decreased overall survival was also seen, but
this did not reach statistical significance, and may reflect small
patient numbers and non-cancer related deaths in a typically
elderly CRC cohort.
Several methods have been described for determining tumour
angiogenesis, including the use of Chalkley count (Hlatky
et al, 2002), endothelial cell proliferation fraction (Hlatky et al,
2002), and pericyte coverage index (Yonenaga et al, 2005). The
Tumour margin 
Tumour centre 
Stromal margin 
Figure 2 Colorectal cancer liver metastases stained with anti-CD31
antibody. The mean MVD was calculated at the stromal margin, tumour
margin, and tumour centre.
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Figure 3 Correlation between MVD at the tumour margin of matched
primary CRCs and liver metastases (vesselsmm
 2).
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Figure 4 (A) Kaplan–Meier curve for disease-free survival following resection of primary CRC vs MVD expression divided into high and low MVD.
(B) Kaplan–Meier curve for disease-free survival following resection of colorectal liver metastases vs MVD expression divided into high and low MVD.
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suse of CD31 MVD analysis as an indicator of angiogenesis
is well described. In this study, MVD analysis was performed
using digital image analysis in preference to traditional tumour
hotspot MVD measurement, which has been shown to be
unreliable in assessing net angiogenic activity (Folkman, 1990;
Takahashi et al, 1997; Hlatky et al, 2002; Subarsky and Hill,
2003). Our results proved to be reliable and reproducible on
statistical testing.
One anomaly that emerges from our study is the unexpected
finding of a higher MVD in pushing primary cancers as compared
to their infiltrative counterparts. As pushing cancers are generally
regarded as having a better prognosis, which we confirmed for
disease-free survival, one might expect them to be associated
with a lower MVD. Studies have also shown the pushing margin in
primary cancers to have a better prognosis than the infiltrative
margin tumours (Jass et al, 1987). This proved not to be the
case and was probably a reflection of the cohort studied which
was of advanced CRC with liver metastases, therefore is not
representative of general spectrum CRC. One explanation could be
the loss of significance between pushing and infiltrative margins
with advanced CRC. Alternatively infiltrative primary and
noncapsulated liver metastases may be less likely amenable to
resection. The influence of the invasive pattern of the primary
tumour and liver metastases on the resectability of the liver
metastases has yet to be looked at.
This cohort was deliberately selected to comprise a high
proportion of advanced cancers with liver metastasis, with
450% of patients having synchronous liver disease. It has been
previously reported that patients who present with metastases at
the time of surgery for primary colon cancer have higher vessel
counts than patients with no evidence of metastases (Takahashi
et al, 1997). Thus the high MVD observed in our pushing cohort
may be a reflection of advanced disease stage.
Although the existence of two invasive phenotypes in CRC is
now well- recognised and their prognostic implications proven, the
biological explanation for their existence remains unexplained.
The finding that pushing cancers tend to form capsulated liver
metastases and infiltrative cancers tend to form non-capsulated
liver metastases would argue for a genetic basis for these
differences. However, one cannot ignore the influence of the
tumour–stromal interaction on the invasive process, and this is
highlighted by our finding of a significant difference in tumour
margin MVD between pushing and infiltrative cancers. Such a
difference was not apparent in liver metastases that reside in the
highly vascularised liver parenchyma. One might hypothesise that
the higher margin MVD observed in pushing cancers was
indicative of better tumour oxygenation, with the assumption that
microvessels are functionally competent (Subarsky and Hill, 2003).
The corollary is that infiltrative cancers, with low margin MVD, are
relatively hypoxic. If such a hypothesis is true, it might be expected
that infiltrative cancers would express higher levels of hypoxia
inducible factor (HIF-1a), which in turn would upregulate a
number of downstream mediators including various proteases,
such as MMP2 (Krishnamachary et al, 2003). These in turn might
facilitate tumour invasion and account for their histological
appearance. The upregulation of HIF-1a in CRC and liver
metastases has been described previously (Mizukami et al, 2004),
but its association with invasive phenotype requires further
investigation.
The current study has highlighted the importance of the invasive
margin in CRC progression and the potential value of tumour–
stromal interactions, as assessed by MVD assessment, in
prognostication. Further investigation is required to determine
the biological mediators, which underlie CRC invasion, to enhance
our understanding of the metastatic process, and to reveal
potential new targets for therapeutic intervention.
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